Skip to main content
Signal8

Harvard Apparatus Regenerative Technology, Inc. (HRGN)

Harvard Apparatus Regenerative Technology Inc., a biotechnology firm currently conducting clinical trials, is dedicated to developing regenerative medical therapies. Its core mission involves addressing conditions affecting the gastrointestinal system and various other organs, which may stem from cancer, trauma, or congenital defects. The company's primary experimental therapy, the Cellspan Esophageal Implant, aims to treat severe esophageal disease. Beyond this, its development pipeline encompasses organ-regeneration technologies designed for the repair or replacement of damaged or diseased organs. This includes product candidates targeting diverse esophageal ailments—such as those caused by traumatic injury, caustic burns, or tissue damage from chemoradiation therapy, as well as birth defects—and solutions for colon and uterine wound reconstruction. Additionally, the company offers consumer health products, including dietary supplements, focusing on personal wellness. Founded in 2009 and headquartered in Holliston, Massachusetts, the company operated as Biostage, Inc. until its rebranding to Harvard Apparatus Regenerative Technology Inc. in July 2023.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Biotechnology

Harvard Apparatus Regenerative Technology Inc. logo

Harvard Apparatus Regenerative Technology Inc.

OTC:HRGNHealthcare
-0.41%$1.96
Mkt Cap$34.49M
Float5.56M
O/S17.58M
Inst Own-
SI<0.1%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$704K
Net Income-$6.87M
Total Assets$2.68M
Free Cash Flow-$3.83M
Debt & Equity
Debt 16%
Equity 84%
Total Debt$199K
Total Equity$1.06M
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in HRGN's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$2.68M
Liabilities$1.62M
Accounts Receivable$16K
Accounts Payable$454K
Inventory$16K
PP&E (Net)$201K
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-31
Revenue$704K$0$0$0$0$0$0$0$0$82K$118K$93K$22K$0$0$0$0
YoY Growth----------30.5%26.9%322.7%-----
Cost of Revenue$646K$270K$24K$0$0$0$0$0$0$116K$139K$48K$11K$0$0$0$0
Gross Profit$58K-$270K-$24K$0$0$0$0$0$0-$34K-$21K$45K$11K$0$0$0$0
Gross Margin8.2%---------41.5%-17.8%48.4%50.0%----
Research and Development$2.65M$2.31M$3.06M$1.74M$1.59M$2.07M$4.85M$3.92M$7.59M$7.6M$4.79M$5.12M$4.56M$4.03M$2.29M$727K$390K
Selling, General, and Administrative$4.32M$5.58M$6.01M$4.41M$7.04M$3.26M$4.02M$3.92M$3.88M$4.49M$6.89M$5.98M$4.27M$2.69M$1.47M$625K$190K
Other$0$0$0$0-$165K-$447K-$473K-$401K$0$0$0$0$0$0$0$0$0
Total Operating Expenses$6.97M$7.89M$9.07M$6.15M$8.47M$4.88M$8.4M$7.44M$11.47M$12.09M$11.68M$11.1M$8.83M$6.71M$3.75M$1.35M$580K
Operating Income (EBIT)-$7.62M-$8.16M-$9.09M-$6.15M-$8.64M-$5.33M-$8.87M-$7.84M-$11.47M-$12.13M-$11.7M-$11.06M-$8.82M-$6.71M-$3.75M-$1.35M-$580K
Operating Margin-1082.2%---------14787.8%-9916.1%-11889.2%-40077.3%----
Interest Expense$8K$38K$14K$100K$0$0$0$0$0$0$0$0$0$0$0$0$0
Interest Income$37K$32K$64K$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Income (Expense)$46K$424K$71K$80K$658K$13K$65K-$89K-$448K$547K-$3K-$4K$0$0$0$0$0
Income Before Tax (EBT)-$6.87M-$7.73M-$9.02M-$6.07M-$7.98M-$4.87M-$8.33M-$7.53M-$11.92M-$11.58M-$11.7M-$11.06M-$8.82M-$6.71M-$3.75M-$1.35M-$580K
Income Tax Expense$0$0$0$6.25M-$530K-$16K-$65K$0$0$0$0$0$0$0$0$0$0
Net Income-$6.87M-$7.73M-$9.02M-$6.07M-$7.98M-$4.87M-$8.33M-$7.53M-$11.92M-$11.58M-$11.7M-$11.06M-$8.82M-$6.71M-$3.75M-$1.35M-$580K
Net Income Margin-975.7%---------14120.7%-9918.6%-11893.5%-40077.3%----
Supplementary Data
EPS-0.42-0.52-0.67-0.55-0.74-0.55-1.20-1.69-6.63-14.49-20.99-28.29-22.78-17.35-9.69-3.49-1.49
Diluted EPS-0.42-0.52-0.67-0.55-0.74-0.55-1.20-1.69-6.63-14.49-21.00-28.29-22.78-17.35-9.69-3.49-1.49
Weighted Average OS16.52M14.79M13.46M11.35M10.06M8.79M6.90M4.46M1.80M799,000557,700391,050387,000387,000387,000387,000390,000
EBITDA-$6.76M-$8.16M-$9.09M-$5.92M-$8.53M-$4.71M-$8.15M-$7.1M-$10.72M-$12.13M-$11.7M-$11.06M-$8.82M-$6.65M-$3.73M-$1.35M-$580K
EBITDA Margin-959.9%---------14787.8%-9916.1%-11889.2%-40077.3%----
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
Assets
Current Assets
Cash and Cash Equivalents$1.35M$2.49M$432K$1.24M$1.24M$1.03M$913K$1.3M$4.04M$2.94M$7.46M$5.27M$14.01M$0$0$0
Short-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$1.35M$2.49M$432K$1.24M$1.24M$1.03M$913K$1.3M$4.04M$2.94M$7.46M$5.27M$14.01M$0$0$0
Accounts Receivable$16K$231K$4K$0$0$77K$0$0$0$42K$21K$32K$22K$0$0$0
Inventory$16K$80K$50K$0$0$550K$0$0$0$291K$75K$207K$38K$0$0$0
Other Current Assets$445K$437K$8K$353K$50K$24K$494K$849K$375K$212K$513K$556K$481K$0$0$0
Total Current Assets$1.83M$3.23M$783K$1.59M$1.29M$1.68M$1.41M$2.15M$4.41M$3.49M$7.97M$5.83M$14.49M$0$0$0
Long-Term Assets
Property, Plant & Equipment Net$201K$304K$73K$196K$279K$399K$585K$479K$632K$1.06M$1.07M$1.38M$575K$438K$187K$0
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$647K$904K$1.76M$610K$295K$0$0$0$0$0$0$0$0$0$0$0
Total Long-Term Assets$848K$1.21M$1.83M$806K$574K$399K$585K$479K$632K$1.06M$1.07M$1.38M$575K$438K$187K$0
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$2.68M$4.44M$2.61M$2.4M$1.87M$2.08M$1.99M$2.63M$5.04M$4.55M$9.04M$7.2M$15.06M$438K$187K$0
Liabilities
Current Liabilities
Accounts Payable$454K$452K$445K$682K$676K$31K$241K$160K$923K$962K$357K$370K$244K$179K$49K$50K
Short-Term Debt$113K$95K$0$99K$110K$391K$102K$0$0$0$0$0$0$0$0$0
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$252K$0$0$0$2.46M$292K$438K$0$0$0$0$0$0$0$0$0
Other Current Liabilities$532K$474K$1K$582K$2K$42K$33K$502K$699K$1.81M$297K$340K$251K$232K$116K$220K
Total Current Liabilities$1.53M$1.02M$968K$1.36M$3.25M$756K$814K$662K$1.62M$2.78M$654K$710K$495K$411K$165K$270K
Long-Term Liabilities
Long-Term Debt$86K$199K$0$48K$59K$195K$89K$0$0$0$0$0$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$0$1.59M$0$0$0$0$0$0$0$0$0$0$0
Total Long-Term Liabilities$86K$199K$0$48K$1.65M$195K$89K$0$0$0$0$0$0$0$0$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$1.62M$1.22M$968K$1.41M$4.89M$951K$903K$662K$1.62M$2.78M$654K$710K$495K$411K$165K$270K
Stockholders' Equity
Preferred Stock$0$0$0$4.18M$0$0$0$0$1.48M$0$0$0$0$0$0$0
Common Stock$176K$159K$139K$122K$108K$94K$82K$57K$25K$171K$141K$79K$77K$0$0$0
Retained Earnings-$106.56M-$99.69M-$91.96M-$83.01M-$76.94M-$68.96M-$64.09M-$55.76M-$48.23M-$36.32M-$24.74M-$13.04M-$1.97M-$12.4M-$5.68M-$1.93M
Comprehensive Income & Other-$12K-$6K$0$0$0$0$0$0$0$0-$8K$1K$0$0$0$0
Other Stockholders' Equity$107.44M$102.75M$93.46M$83.88M$73.8M$69.99M$65.1M$57.68M$51.63M$37.92M$32.99M$19.45M$16.47M$12.43M$5.71M$1.66M
Total Equity$1.06M$3.22M$1.65M$989K-$3.03M$1.13M$1.09M$1.97M$3.42M$1.77M$8.39M$6.49M$14.57M$27K$22K-$270K
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$2.68M$4.44M$2.61M$2.4M$1.87M$2.08M$1.99M$2.63M$5.04M$4.55M$9.04M$7.2M$15.06M$438K$187K$0
Supplementary Data
Total Debt$199K$294K$48K$147K$169K$586K$191K$0$0$0$0$0$0$0$0$0
Net Debt-$1.15M-$2.19M-$384K-$1.09M-$1.07M-$440K-$722K-$1.3M-$4.04M-$2.94M-$7.46M-$5.27M-$14.01M$0$0$0
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-31
Operating Activities
Net Income-$6.87M-$7.73M-$9.02M-$6.07M-$7.98M-$4.87M-$8.33M-$7.53M-$11.92M-$11.58M-$11.7M-$11.06M-$8.82M-$6.71M-$3.75M-$1.35M-$580K
Depreciation & Amortization$103K$167K$134K$52K$107K$184K$311K$261K$413K$454K$478K$363K$158K$59K$21K$0$0
Deferred Income Tax$0$0$0$0$0$0$0$0$0$0-$4.44M-$2.93M-$1.53M-$511K$0$0$0
Stock-Based Compensation$2.01M$2.4M$3.46M$1.03M$980K$1.14M$1.65M$755K$693K$1.33M$3.97M$2.56M$1.37M$511K$261K$105K$0
Changes in Working Capital:
  Accounts Receivable$215K-$227K-$4K$0$0$0$0$0$42K-$21K-$16K-$5K$0$0$0$0$0
  Inventory$64K-$30K-$50K$0$0$0$0$0$0$75K$132K-$169K-$38K$0$0$0$0
  Accounts Payable$2K$7K-$237K$6K$645K-$210K$81K-$763K-$43K$472K-$13K$126K$65K$130K-$3K$46K$0
  Other Working Capital$647K$561K-$1.3M-$120K$4.04M-$278K$292K-$451K-$700K$1.52M-$58K$376K-$424K$116K-$101K$153K$0
Total Working Capital Change$928K$311K-$1.59M-$114K$4.69M-$488K$373K-$1.21M-$701K$1.29M$74K$140K-$397K$246K-$104K$199K$70K
Other Non-Cash Items$0$311K-$1.51M-$2K-$423K-$16K-$65K$89K$497K-$547K$4.44M$2.93M$1.53M$511K$0$0$30K
Net Cash from Operating-$3.83M-$4.85M-$6.94M-$5.11M-$2.63M-$4.04M-$6.06M-$7.64M-$11.01M-$9.06M-$7.19M-$7.99M-$7.69M-$5.9M-$3.57M-$1.05M-$480K
Investing Activities
Capital Expenditures$0$0-$11K-$5K$0-$7K-$129K-$131K-$136K-$302K-$176K-$1.16M-$295K-$310K-$207K-$1K$0
Acquisitions$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Purchases of Investments$0$0-$2.52M$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Sales of Investments$0$0$2.52M$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Investing Activities$0$0$0$0$0$0$0$64K$0$0$1K$0$0$0$0$0$0
Net Cash from Investing$0$0-$11K-$5K$0-$7K-$129K-$67K-$136K-$302K-$175K-$1.16M-$295K-$310K-$207K-$1K$0
Financing Activities
Debt Repaid-----------------
Common Stock Issuance$2.7M$6.48M$5.99M$5.06M$2.84M$1.06M$1.81M$5.32M$6.8M$4.84M$9.55M$418K$3K$0$0$0$0
Common Stock Repurchases$0$0$0$0$0-$42K$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$0$6.91M$6.14M$5.06M$2.84M$4.16M$5.8M$5.02M$12.25M$4.84M$9.55M$418K$21.99M$6.21M$3.78M$1.05M$480K
Net Cash from Financing$2.7M$6.91M$6.14M$5.06M$2.84M$4.16M$5.8M$5.02M$12.25M$4.84M$9.55M$418K$21.99M$6.21M$3.78M$1.05M$480K
Forex Effect-$6K-$6K$0$0$0$0$0$0$0$0-$9K$1K$0$0$0$0$0
Net Change in Cash-$1.13M$2.05M-$809K-$51K$216K$113K-$392K-$2.68M$1.1M-$4.51M$2.18M-$8.74M$14.01M$0$0$0$0
Supplementary Data
Operating Cash Flow-$3.83M-$4.85M-$6.94M-$5.11M-$2.63M-$4.04M-$6.06M-$7.64M-$11.01M-$9.06M-$7.19M-$7.99M-$7.69M-$5.9M-$3.57M-$1.05M-$480K
Capital Expenditure$0$0-$11K-$5K$0-$7K-$129K-$131K-$136K-$302K-$176K-$1.16M-$295K-$310K-$207K-$1K$0
Free Cash Flow-$3.83M-$4.85M-$6.95M-$5.11M-$2.63M-$4.05M-$6.19M-$7.77M-$11.15M-$9.36M-$7.36M-$9.16M-$7.98M-$6.21M-$3.78M-$1.05M-$480K
Cash at Beginning$2.49M$432K$1.24M$1.29M$1.08M$963K$1.35M$4.04M$2.94M$7.46M$5.27M$14.01M$0$0$0$0$0
Cash at End$1.35M$2.49M$432K$1.24M$1.29M$1.08M$963K$1.35M$4.04M$2.94M$7.46M$5.27M$14.01M$0$0$0$0